With a total of 108,200 SF of facility space, 23 Sycamore will be divided as 30% office, 30% cGMP, 30% MEP/Manufacturing, and 10% warehouse lobby space . Square footage is divided amongst three floors:
58,700 SF on the first floor, 49,500 SF on a second floor, and 33,000 SF for the mezzanine.

The 37-foot-5-inch maximum height ceiling heights and, 60-foot-by-29-inch column spacing is ideal for GMP biomanufacturing and its related mechanical equipment.

There are six loading docks (7,800 SF per/ dock) supporting logistics and transportation, while a new service elevator will provide access to the mechanical mezzanine.

Upgraded electrical power services will include 3 Phase, 480v, 6,000-amp service to support production and equipment needs. An enhanced HVAC system will also be installed.

The rooftop infrastructure supports biomanufacturing equipment housing.

Boston’s competitive industrial market makes 23 Sycamore a prominent urban GMP offering within just 4 miles of Cambridge.

The Property sits in a community of other urban industrial facilities and ready for growth in the Life Sciences sector. Early entrants can shape this community, establishing and leveraging a new biomanufacturing cluster.

The property is well-located with easy access to major highways including Route 28 and the I-93, and close proximity to core R&D hubs in the Boston market (Cambridge, Chelsea, Boston metro) for efficient transportation among properties by biomedical companies.

All necessary amenities to keep employees and visitors healthy and engaged are within a 10-minute drive. Access food, accommodations, fitness facilities and green space in this thriving community.